Company intelligence / Profile preview

Atraverse Medical

Cardiff by the Sea, California, United Statesatraversemedical.com ↗

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Atraverse Medical has developed the HOTWIRE™ radiofrequency guidewire system, which received FDA 510(k) clearance in May 2024. The product is commercially available and has been used in nearly 1,000 clinical procedures as of mid-2025. Early results indicate strong adoption due to workflow efficiency and universal sheath compatibility[4][6][8].

Therapeutic areas: Cardiovascular
Modalities: DeviceRadiofrequency-based device (RF technology)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

HOTWIRE

Commercial

Indications: Left heart access procedures, Endocardial ablation, Left atrial appendage closure, Mitral valve repair

Beyond the preview

Go deeper on Atraverse Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atraverse Medical.

Explore the full profile